Correlation Between Mauna Kea and Acticor Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mauna Kea and Acticor Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mauna Kea and Acticor Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mauna Kea Technologies and Acticor Biotech SAS, you can compare the effects of market volatilities on Mauna Kea and Acticor Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mauna Kea with a short position of Acticor Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mauna Kea and Acticor Biotech.

Diversification Opportunities for Mauna Kea and Acticor Biotech

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Mauna and Acticor is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Mauna Kea Technologies and Acticor Biotech SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acticor Biotech SAS and Mauna Kea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mauna Kea Technologies are associated (or correlated) with Acticor Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acticor Biotech SAS has no effect on the direction of Mauna Kea i.e., Mauna Kea and Acticor Biotech go up and down completely randomly.

Pair Corralation between Mauna Kea and Acticor Biotech

Assuming the 90 days trading horizon Mauna Kea Technologies is expected to under-perform the Acticor Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Mauna Kea Technologies is 4.02 times less risky than Acticor Biotech. The stock trades about -0.37 of its potential returns per unit of risk. The Acticor Biotech SAS is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  58.00  in Acticor Biotech SAS on September 5, 2024 and sell it today you would lose (29.00) from holding Acticor Biotech SAS or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy97.67%
ValuesDaily Returns

Mauna Kea Technologies  vs.  Acticor Biotech SAS

 Performance 
       Timeline  
Mauna Kea Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mauna Kea Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Acticor Biotech SAS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Mauna Kea and Acticor Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mauna Kea and Acticor Biotech

The main advantage of trading using opposite Mauna Kea and Acticor Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mauna Kea position performs unexpectedly, Acticor Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acticor Biotech will offset losses from the drop in Acticor Biotech's long position.
The idea behind Mauna Kea Technologies and Acticor Biotech SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Bonds Directory
Find actively traded corporate debentures issued by US companies